National Foundation for Cancer Research Parent

We Make Cures Possible

aka Cancer Research America - NFCR   |   Rockville, MD   |

Learn how to support this organization
GuideStar Charity Check

National Foundation for Cancer Research

EIN: 04-2531031


The National Foundation for Cancer Research (NFCR) was founded in 1973 to support cancer research and public education relating to prevention, early diagnosis, better treatments and, ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure--cures for all types of cancer.

Notes from the nonprofit

This year, NFCR celebrates its 50 Year Anniversary. In those 50 years, NFCR has been focused on funding high-risk – high reward research to find cures to all cancers. During this time, the organization has evolved but one thing has consistently remained the same – NFCR’s motivation and unwavering commitment to fund impact-driven research, improve patient lives, educate the public about cancer, and ultimately find a cure. In 2023, NFCR introduced a new logo and tagline – We Make Cures Possible. Through our unique approach to scientific research and discovery – a collaborative and holistic view of cancer and research process – NFCR funds scientists who are unrestricted in their work, where they have the freedom to discover in their quest to find breakthrough treatments and therapies, with one goal in mind – to improve patient care, find cures, and save lives.

Ruling year info


President and Chief Executive Officer

Dr. Sujuan Ba Ph.D.

Main address

5515 Security Lane Suite 1105

Rockville, MD 20852 USA

Show more contact info



Subject area info



Population served info


NTEE code info

Cancer (G30)

Cancer Research (H30)

Fund Raising and/or Fund Distribution (U12)

What we aim to solve

SOURCE: Self-reported by organization

Cancer is newly diagnosed in 1.7 million Americans per year and annually claims the lives of 600 thousand of the country's men, women and children. Although tremendous strides have been made in the scientific understanding of the disease and development of measures to counter it, so very much more progress is necessary in laboratories, clinics and hospitals in order to produce better treatments, earlier diagnoses, preventive measures and, ultimately, cures for this most dreaded of ailments.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Cancer Research

Grants to support Cancer Researchers in the areas of cutting-edge basic and translational scientific research

Population(s) Served

Educational and awareness-building materials provided at no cost to more than 20 million U.S. residents per year in the areas of cancer prevention, early detection and treatment

Population(s) Served

Where we work

Affiliations & memberships

Better Business Bureau Wise Giving Alliance - Organization 2016

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

NFCR research funding promotes and facilitates worldwide collaboration among scientists to accelerate the pace of discovery from laboratory bench to patient bedside. We support of laboratories and dozens of scientists over the past 50 years has helped make possible cancer treatments that are saving lives today. In addition, NFCR provides cancer information to more than 25 million U.S. households annually to raise public awareness about cancer prevention and early diagnosis.

NFCR seeks to pool immediately deployable funding to provide support for both basic and translational cancer research in and with some of America's best laboratories and their leading directors and teams. Also, we aim to educate more than 25 million U.S. households per year on the steps they and their loved ones can take to reduce cancer risk and better understand the disease.

NFCR offers robust research grants to some of America's best cancer researchers, funding that is unavailable from many other more traditional sources, such as universities, government agencies or corporations. We also have cultivated a constituency base of over 25 million U.S. households to whom we offer succinct, digestible cancer research updates, as well as early diagnosis and preventive best practices. This is all performed in conjunction with a world-class Scientific Advisory Board and is aided by the platform afforded by our creation and annual presentation of one of the global cancer research communities' most prestigious awards: the Szent-Gyorgyi Prize for Progress in Cancer Research, named after NFCR's Nobel Prize winning co-founder, Albert Szent-Gyorgyi.

NFCR has provided more than $410 million for cutting-edge cancer research. We have supported hundreds of scientists since our founding in 1973. And we won't be finished until there is a cure for all cancer types.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

done We shared information about our current feedback practices.
  • How is your organization using feedback from the people you serve?

    To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To make fundamental changes to our programs and/or operations, To inform the development of new programs/projects, To strengthen relationships with the people we serve, To understand people's needs and how we can help them achieve their goals

  • Which of the following feedback practices does your organization routinely carry out?

    We collect feedback from the people we serve at least annually, We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We look for patterns in feedback based on people’s interactions with us (e.g., site, frequency of service, etc.), We engage the people who provide feedback in looking for ways we can improve in response, We act on the feedback we receive, We share the feedback we received with the people we serve, We tell the people who gave us feedback how we acted on their feedback, We ask the people who gave us feedback how well they think we responded

  • What challenges does the organization face when collecting feedback?

    It is difficult to get the people we serve to respond to requests for feedback, It is difficult to find the ongoing funding to support feedback collection, Staff find it hard to prioritize feedback collection and review due to lack of time


National Foundation for Cancer Research
Fiscal year: Jan 01 - Dec 31

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022 info

SOURCE: IRS Form 990


Average of 3.36 over 10 years

Months of cash in 2022 info

SOURCE: IRS Form 990


Average of 2.2 over 10 years

Fringe rate in 2022 info

SOURCE: IRS Form 990


Average of 16% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

National Foundation for Cancer Research

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

National Foundation for Cancer Research

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

National Foundation for Cancer Research

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of National Foundation for Cancer Research’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2018 2019 2020 2021 2022
Unrestricted surplus (deficit) before depreciation -$2,131,020 -$3,045,519 $988,357 $234,768 -$915,937
As % of expenses -14.1% -21.0% 9.2% 2.3% -10.8%
Unrestricted surplus (deficit) after depreciation -$2,166,961 -$3,083,615 $950,608 $200,358 -$930,703
As % of expenses -14.3% -21.2% 8.8% 2.0% -11.0%
Revenue composition info
Total revenue (unrestricted & restricted) $13,696,895 $10,937,905 $11,465,290 $10,081,253 $8,408,059
Total revenue, % change over prior year 5.7% -20.1% 4.8% -12.1% -16.6%
Program services revenue 0.0% 0.0% 0.0% 0.0% 0.0%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 2.1% 2.4% 1.8% 2.4% 2.4%
Government grants 0.0% 0.0% 0.1% 7.9% 0.0%
All other grants and contributions 92.6% 90.1% 95.7% 85.7% 97.3%
Other revenue 5.2% 7.5% 2.4% 3.9% 0.3%
Expense composition info
Total expenses before depreciation $15,111,790 $14,494,278 $10,792,252 $10,160,097 $8,470,142
Total expenses, % change over prior year 12.8% -4.1% -25.5% -5.9% -16.6%
Personnel 18.9% 19.9% 24.6% 20.6% 25.9%
Professional fees 3.6% 3.3% 3.7% 4.2% 5.3%
Occupancy 1.6% 1.6% 2.1% 2.3% 2.7%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 26.5% 42.9% 39.9% 42.3% 27.0%
All other expenses 49.4% 32.3% 29.8% 30.7% 39.1%
Full cost components (estimated) info 2018 2019 2020 2021 2022
Total expenses (after depreciation) $15,147,731 $14,532,374 $10,830,001 $10,194,507 $8,484,908
One month of savings $1,259,316 $1,207,857 $899,354 $846,675 $705,845
Debt principal payment $0 $0 $0 $200,000 $200,000
Fixed asset additions $50,440 $0 $0 $0 $0
Total full costs (estimated) $16,457,487 $15,740,231 $11,729,355 $11,241,182 $9,390,753

Capital structure indicators

Liquidity info 2018 2019 2020 2021 2022
Months of cash 0.9 1.3 2.4 2.6 2.8
Months of cash and investments 6.8 4.9 8.8 9.2 9.7
Months of estimated liquid unrestricted net assets 5.6 3.3 5.5 6.1 6.0
Balance sheet composition info 2018 2019 2020 2021 2022
Cash $1,168,990 $1,531,154 $2,126,572 $2,211,197 $1,977,541
Investments $7,371,171 $4,349,518 $5,791,973 $5,539,340 $4,895,234
Receivables $106,247 $201,229 $70,919 $87,021 $58,323
Gross land, buildings, equipment (LBE) $387,823 $387,822 $393,083 $218,655 $226,556
Accumulated depreciation (as a % of LBE) 64.5% 74.3% 82.9% 83.6% 87.2%
Liabilities (as a % of assets) 22.5% 28.7% 27.4% 24.0% 29.0%
Unrestricted net assets $7,141,083 $4,057,468 $5,008,076 $5,208,434 $4,277,731
Temporarily restricted net assets $1,213,987 N/A N/A N/A N/A
Permanently restricted net assets $1,941,507 N/A N/A N/A N/A
Total restricted net assets $3,155,494 $3,472,001 $3,913,406 $4,015,442 $3,329,851
Total net assets $10,296,577 $7,529,469 $8,921,482 $9,223,876 $7,607,582

Key data checks

Key data checks info 2018 2019 2020 2021 2022
Material data errors No No No No No


The people, governance practices, and partners that make the organization tick.

Form 1023/1024 is not available for this organization

President and Chief Executive Officer

Dr. Sujuan Ba Ph.D.

Dr. Ba is recognized as one of the “Top 300 Women Leaders in Global Health" by the Global Health Programme at the Graduate Institute of International and Development Studies. Under her leadership, NFCR has established a powerful network of research centers/laboratories in the US and around the world. One of the high-profile and significant research programs emerging from this collaborative approach was the ScreenSaver-LifeSaver Project. Dr. Ba established a partnership between NFCR, United Devices, Inc., Intel Corp., and Oxford University to launch a distributed computing technology-based application linking together more than 3 million PC users globally to create the world's largest supercomputer which sped up the drug screening process. This program enabled scientists to perform virtual screenings of 3.5 billion small molecules against 12 target proteins to identify new anti-cancer drug candidates. Dr. Ba has led the Tissue Bank Consortium in Asia to promote the best practices for biorepositories and biobanks. This project is proclaimed an exemplary international platform for private, public and government partnership for international collaboration to advance cancer research. Dr. Ba led the launch of Szent-Györgyi Prize for Progress in Cancer Research, now an internationally recognized prize for outstanding scientific achievement. Dr. Ba serves on the executive committee of the GBM-AGILE Trial, an initiative to improve the survival of GBM patients with a global force of over 150 neurosurgeons, neuro-oncologists, pathologists, imagers, basic and clinical neuro scientists. This is a model that aims to breakdown silos and build knowledge bases to ensure that precision medicine is available to patients worldwide.

Number of employees

Source: IRS Form 990

National Foundation for Cancer Research

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

National Foundation for Cancer Research

Highest paid employees

SOURCE: IRS Form 990

Show data for fiscal year
Compensation data
Download up to 5 most recent years of highest paid employee data for this organization

National Foundation for Cancer Research

Board of directors
as of 08/31/2023
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board chair

Dr. Alfred Slanetz

Geneius Biotechnology Inc.

Term: 2023 - 2026

Edward West

Law Offices of Edward S. West

Judith Barhard

Councilor, Buchanan & Mitchell, PC

Karen Burke

Mt. Sinai Medical Center

Lance Kawaguchi

Cure Brain Cancer Foundation

Brian Leyland-Jones

AIM-HI Accelerator Fund

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes

Organizational demographics

SOURCE: Self-reported; last updated 3/15/2022

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.


The organization's leader identifies as:

Race & ethnicity
Asian/Asian American
Gender identity
Sexual orientation
Decline to state
Disability status
Person without a disability

Race & ethnicity

No data

Gender identity

No data


No data

Sexual orientation

No data


No data

Equity strategies

Last updated: 08/30/2023

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

  • We disaggregate data to adjust programming goals to keep pace with changing needs of the communities we support.
  • We employ non-traditional ways of gathering feedback on programs and trainings, which may include interviews, roundtables, and external reviews with/by community stakeholders.
  • We have long-term strategic plans and measurable goals for creating a culture such that one’s race identity has no influence on how they fare within the organization.
Policies and processes
  • We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
  • We have community representation at the board level, either on the board itself or through a community advisory board.
  • We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
  • We measure and then disaggregate job satisfaction and retention data by race, function, level, and/or team.
  • We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.


Fiscal year ending

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities
Gross receipts from fundraising
Retained by organization
Paid to fundraiser